{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:02:23Z","timestamp":1788346943498,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.phrs.2022.106147","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T02:01:43Z","timestamp":1645840903000},"page":"106147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["CTLA4-Ig mediated immunosuppression favors immunotolerance and restores graft in mouse airway transplants"],"prefix":"10.1016","volume":"178","author":[{"given":"Mohammad Afzal","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"Shamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Altuhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala Abdalrahman","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Mohammed","family":"Assiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter Clemens","family":"Broering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.phrs.2022.106147_bib1","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1517\/13543784.9.9.2147","article-title":"CTLA4-Ig: a novel immunosuppressive agent","volume":"9","author":"Najafian","year":"2000","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"2","key":"10.1016\/j.phrs.2022.106147_bib2","first-page":"81","article-title":"CTLA4-Ig: progress with a novel immunosuppressive agent in experimental solid organ transplantation","volume":"8","author":"Pagani","year":"1997","journal-title":"BioDrugs Clin. Immunother. Biopharm. Gene Ther."},{"issue":"3","key":"10.1016\/j.phrs.2022.106147_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.immuni.2006.03.001","article-title":"CTLA4Ig: bridging the basic immunology with clinical application","volume":"24","author":"Bluestone","year":"2006","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.phrs.2022.106147_bib4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/JLB.5RU0718-288R","article-title":"Complement factor and T-cell interactions during alloimmune inflammation in transplantation","volume":"105","author":"Khan","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"12","key":"10.1016\/j.phrs.2022.106147_bib5","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1111\/ajt.13872","article-title":"The immunosuppressive effect of CTLA4 immunoglobulin is dependent on regulatory T cells at low but not high doses","volume":"16","author":"Schwarz","year":"2016","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.phrs.2022.106147_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2484825","article-title":"CTLA4Ig improves murine iTreg induction via TGFbeta and suppressor function in vitro","volume":"2018","author":"Pilat","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"11","key":"10.1016\/j.phrs.2022.106147_bib7","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/CIRCRESAHA.111.250167","article-title":"CD4+ T cells and complement independently mediate graft ischemia in the rejection of mouse orthotopic tracheal transplants","volume":"109","author":"Khan","year":"2011","journal-title":"Circ. Res."},{"issue":"15","key":"10.1016\/j.phrs.2022.106147_bib8","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1073\/pnas.1217991110","article-title":"Targeting complement component 5a promotes vascular integrity and limits airway remodeling","volume":"110","author":"Khan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.phrs.2022.106147_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-4614-4118-2_16","article-title":"Complement-mediated microvascular injury leads to chronic rejection","volume":"734","author":"Khan","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1010","key":"10.1016\/j.phrs.2022.106147_bib10","article-title":"C5a blockade increases regulatory T cell numbers and protects against microvascular loss and epithelial damage in mouse airway allografts","volume":"9","author":"Khan","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2022.106147_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/cei.12713","article-title":"Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective","volume":"183","author":"Khan","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106147_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12967-020-02305-z","article-title":"Hypoxia-induced complement dysregulation is associated with microvascular impairments in mouse tracheal transplants","volume":"18","author":"Khan","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phrs.2022.106147_bib13","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2119\/molmed.2016.00050","article-title":"T regulatory cell mediated immunotherapy for solid organ transplantation: a clinical perspective","volume":"22","author":"Khan","year":"2016","journal-title":"Mol. Med."},{"key":"10.1016\/j.phrs.2022.106147_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12967-015-0565-2","article-title":"Complement mediators: key regulators of airway tissue remodeling in asthma","volume":"13","author":"Khan","year":"2015","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.phrs.2022.106147_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12929-015-0151-1","article-title":"Complement and macrophage crosstalk during process of angiogenesis in tumor progression","volume":"22","author":"Khan","year":"2015","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2022.106147_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.rmed.2014.01.005","article-title":"Complement components as potential therapeutic targets for asthma treatment","volume":"108","author":"Khan","year":"2014","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.phrs.2022.106147_bib17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/TP.0000000000002571","article-title":"Preservation of microvascular integrity in murine orthotopic tracheal allografts by clopidogrel","volume":"103","author":"Heim","year":"2019","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.phrs.2022.106147_bib18","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.4049\/jimmunol.1400146","article-title":"Immunological priming requires regulatory T cells and IL-10-producing macrophages to accelerate resolution from severe lung inflammation","volume":"192","author":"Aggarwal","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2022.106147_bib19","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jaci.2010.01.018","article-title":"Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model","volume":"125","author":"Amu","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106147_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2337\/diabetes.55.01.06.db05-0613","article-title":"Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance","volume":"55","author":"Battaglia","year":"2006","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.phrs.2022.106147_bib21","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"177","author":"Battaglia","year":"2006","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106147_bib22","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1128\/MCB.01206-10","article-title":"Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival","volume":"31","author":"Beier","year":"2011","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2022.106147_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jbspin.2012.04.010","article-title":"Regulatory B cells play a key role in immune system balance","volume":"80","author":"Berthelot","year":"2013","journal-title":"Jt. Bone Spine"},{"issue":"6","key":"10.1016\/j.phrs.2022.106147_bib24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1183\/09031936.00093207","article-title":"CTLA-4-mediated regulatory phenotype of T-cells in tolerant lung recipients","volume":"31","author":"Botturi","year":"2008","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.phrs.2022.106147_bib25","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/TP.0000000000000421","article-title":"CTLA4-Ig preserves thymus-derived T regulatory cells","volume":"98","author":"Ahmadi","year":"2014","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.phrs.2022.106147_bib26","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.4049\/jimmunol.1300830","article-title":"CTLA4Ig inhibits effector T cells through regulatory T cells and TGF-beta","volume":"191","author":"Deppong","year":"2013","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106147_bib27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/intimm\/dxn007","article-title":"CTLA-4 x Ig converts naive CD4+CD25- T cells into CD4+CD25+ regulatory T cells","volume":"20","author":"Razmara","year":"2008","journal-title":"Int Immunol."},{"key":"10.1016\/j.phrs.2022.106147_bib28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1152\/ajplung.00162.2012","article-title":"New methods for monitoring dynamic airway tissue oxygenation and perfusion in experimental and clinical transplantation","volume":"303","author":"Khan","year":"2012","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"10","key":"10.1016\/j.phrs.2022.106147_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077136","article-title":"Aspergillus fumigatus invasion increases with progressive airway ischemia","volume":"8","author":"Hsu","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.phrs.2022.106147_bib30","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1172\/JCI46192","article-title":"Adenovirus-mediated HIF-1alpha gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection","volume":"121","author":"Jiang","year":"2011","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.phrs.2022.106147_bib31","first-page":"1095","article-title":"Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival","volume":"43","author":"Comer","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2022.106147_bib32","first-page":"163","article-title":"Enhanced reactivity in mixed leukocyte cultures after separation of mononuclear cells on Ficoll-Hypaque","volume":"4","author":"Bain","year":"1972","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.phrs.2022.106147_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clim.2016.11.011","article-title":"FOXP3+ regulatory T cell ameliorates microvasculature in the rejection of mouse orthotopic tracheal transplants","volume":"174","author":"Khan","year":"2017","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.phrs.2022.106147_bib34","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1172\/JCI32311","article-title":"Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis","volume":"117","author":"Babu","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.phrs.2022.106147_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s13287-019-1397-4","article-title":"iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants","volume":"10","author":"Khan","year":"2019","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2022.106147_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0002-9440(10)64529-4","article-title":"The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system","volume":"157","author":"Swaisgood","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106147_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1465-9921-6-30","article-title":"Quantification of collagen and proteoglycan deposition in a murine model of airway remodelling","volume":"6","author":"Reinhardt","year":"2005","journal-title":"Respir. Res."},{"issue":"10","key":"10.1016\/j.phrs.2022.106147_bib38","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1111\/ajt.12405","article-title":"Immune cell-derived C3a and C5a costimulate human T cell alloimmunity","volume":"13","author":"Cravedi","year":"2013","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.phrs.2022.106147_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.19.1.225","article-title":"Complexities of CD28\/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation","volume":"19","author":"Salomon","year":"2001","journal-title":"Annu Rev. Immunol."},{"issue":"12","key":"10.1016\/j.phrs.2022.106147_bib40","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015537","article-title":"T-cell costimulatory blockade in organ transplantation","volume":"3","author":"Maltzman","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"19","key":"10.1016\/j.phrs.2022.106147_bib41","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJM200511103531919","article-title":"Costimulation blockade with belatacept in renal transplantation","volume":"353","author":"Dharnidharka","year":"2005","journal-title":"New Engl. J. Med."},{"issue":"11","key":"10.1016\/j.phrs.2022.106147_bib42","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1097\/TP.0000000000001344","article-title":"Costimulation blockade in kidney transplantation: an update","volume":"100","author":"Malvezzi","year":"2016","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.phrs.2022.106147_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92033","article-title":"CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients","volume":"2","author":"Khiew","year":"2017","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.phrs.2022.106147_bib44","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1177\/1352458516662727","article-title":"ACCLAIM: a randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis","volume":"23","author":"Khoury","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.phrs.2022.106147_bib45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2172-14-34","article-title":"CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients","volume":"14","author":"Pieper","year":"2013","journal-title":"BMC Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106147_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/13543784.2020.1727885","article-title":"CTLA4-Ig (abatacept): a promising investigational drug for use in type 1 diabetes","volume":"29","author":"Rachid","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.phrs.2022.106147_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2347827","article-title":"CTLA4-Ig abatacept ameliorates proteinuria by regulating circulating Treg\/IL-17 in adriamycin-induced nephropathy rats","volume":"2020","author":"Shuai","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"12","key":"10.1016\/j.phrs.2022.106147_bib48","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1097\/00007890-199457120-00002","article-title":"Transplantation tolerance induced by CTLA4-Ig","volume":"57","author":"Pearson","year":"1994","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.phrs.2022.106147_bib49","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1600-6143.2011.03929.x","article-title":"Deleterious effect of CTLA4-Ig on a treg-dependent transplant model","volume":"12","author":"Riella","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.phrs.2022.106147_bib50","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1186\/ar1688","article-title":"The evolving clinical profile of abatacept (CTLA4-Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis","volume":"7 Suppl 2","author":"Ruderman","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.phrs.2022.106147_bib51","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1600-6143.2011.03561.x","article-title":"Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice","volume":"11","author":"Raedler","year":"2011","journal-title":"Am. J. Transpl."},{"issue":"3","key":"10.1016\/j.phrs.2022.106147_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031269","article-title":"Targeting interleukin-10 restores graft microvascular supply and airway epithelium in rejecting allografts","volume":"23","author":"Kazmi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2022.106147_bib53","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3390\/cells10051248","article-title":"IL-10 mediated immunomodulation limits subepithelial fibrosis and repairs airway epithelium in rejecting airway allografts","volume":"10","author":"Khan","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.phrs.2022.106147_bib54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1126\/scitranslmed.3000266","article-title":"Functional repair of human donor lungs by IL-10 gene therapy","volume":"1","author":"Cypel","year":"2009","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2022.106147_bib55","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1128\/IAI.73.1.523-531.2005","article-title":"Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients","volume":"73","author":"Lundgren","year":"2005","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.phrs.2022.106147_bib56","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1165\/rcmb.2007-0257RC","article-title":"Maintenance of airway epithelium in acutely rejected orthotopic vascularized mouse lung transplants","volume":"37","author":"Okazaki","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"10","key":"10.1016\/j.phrs.2022.106147_bib57","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0198-8859(00)00175-0","article-title":"Airway epithelial cell damage mediated by antigen-specific T cells: implications in lung allograft rejection","volume":"61","author":"Smith","year":"2000","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106147_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0034-5687(01)00260-2","article-title":"Regulation of experimental lung inflammation","volume":"128","author":"Lentsch","year":"2001","journal-title":"Respir. Physiol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106147_bib59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1600-6143.2004.00333.x","article-title":"Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease","volume":"4","author":"Fernandez","year":"2004","journal-title":"Am. J. Transpl."},{"issue":"3","key":"10.1016\/j.phrs.2022.106147_bib60","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4161\/mabs.23976","article-title":"Immune suppression in cynomolgus monkeys by XPro9523: an improved CTLA4-Ig fusion with enhanced binding to CD80, CD86 and neonatal Fc receptor FcRn","volume":"5","author":"Bernett","year":"2013","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.phrs.2022.106147_bib61","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s13075-021-02691-9","article-title":"CTLA4-Ig treatment induces M1-M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients","volume":"23","author":"Cutolo","year":"2021","journal-title":"Arthritis Res. Ther."},{"issue":"6581","key":"10.1016\/j.phrs.2022.106147_bib62","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/381434a0","article-title":"Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways","volume":"381","author":"Larsen","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2022.106147_bib63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4049\/jimmunol.1002777","article-title":"IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival","volume":"188","author":"Sucher","year":"2012","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.phrs.2022.106147_bib64","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1084\/jem.187.12.2037","article-title":"Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance","volume":"187","author":"Wekerle","year":"1998","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.phrs.2022.106147_bib65","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/ajt.13154","article-title":"Rapamycin and CTLA4Ig synergize to induce stable mixed chimerism without the need for CD40 blockade","volume":"15","author":"Pilat","year":"2015","journal-title":"Am. J. Transpl."},{"issue":"6","key":"10.1016\/j.phrs.2022.106147_bib66","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.4049\/jimmunol.1300830","article-title":"CTLA4Ig inhibits effector T cells through regulatory T cells and TGF-\u03b2","volume":"191","author":"Deppong","year":"2013","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106147_bib67","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2460\/ajvr.72.4.541","article-title":"Effect of cyclosporine, dexamethasone, and human CTLA4-Ig on production of cytokines in lymphocytes of clinically normal cats and cats undergoing renal transplantation","volume":"72","author":"Aronson","year":"2011","journal-title":"Am. J. Vet. Res."},{"issue":"6","key":"10.1016\/j.phrs.2022.106147_bib68","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1172\/JCI72273","article-title":"Complement as a multifaceted modulator of kidney transplant injury","volume":"124","author":"Cravedi","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.phrs.2022.106147_bib69","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/ajt.16218","article-title":"CTLA4-Ig prolongs graft survival specifically in young but not old mice","volume":"21","author":"Heinbokel","year":"2021","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.phrs.2022.106147_bib70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.trim.2008.05.005","article-title":"CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice","volume":"19","author":"Yang","year":"2008","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.phrs.2022.106147_bib71","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fimmu.2013.00253","article-title":"Peripheral and thymic foxp3(+) regulatory T cells in search of origin, distinction, and function","volume":"4","author":"Dhamne","year":"2013","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106147_bib72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4049\/jimmunol.1290033","article-title":"Comment on \u201cExpression of Helios in peripherally induced Foxp3+ regulatory T cells\u201d","volume":"189","author":"Elkord","year":"2012","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106147_bib73","doi-asserted-by":"crossref","first-page":"976","DOI":"10.4049\/jimmunol.1102964","article-title":"Expression of Helios in peripherally induced Foxp3+ regulatory T cells","volume":"188","author":"Gottschalk","year":"2012","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2022.106147_bib74","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.phrs.2022.106147_bib75","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.4049\/jimmunol.1090105","article-title":"Comment on \"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"185","author":"Verhagen","year":"2010","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2022.106147_bib76","doi-asserted-by":"crossref","first-page":"7054","DOI":"10.4049\/jimmunol.0803054","article-title":"Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: implication in human renal transplant acceptance","volume":"183","author":"Bahri","year":"2009","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.phrs.2022.106147_bib77","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJMoa050085","article-title":"Study, costimulation blockade with belatacept in renal transplantation","volume":"353","author":"Vincenti","year":"2005","journal-title":"New Engl. J. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822000925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822000925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:30:22Z","timestamp":1760913022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822000925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":77,"alternative-id":["S1043661822000925"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106147","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CTLA4-Ig mediated immunosuppression favors immunotolerance and restores graft in mouse airway transplants","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106147"}}